MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.76 -0.11 (-6.29%)	0.03 (1.81%)	0.01 (0.57%)	-0.11 (-6.29%)	---	---	-0.11 (-6.29%)	-0.11 (-6.29%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -18.3256
Diluted P/E:: -18.3256
RSI(14) 1m:: 52.82
VWAP:: 1.63
RVol:: 0.0959

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	2.45 -0.08 (-3.16%)	Oct 16 06:48
1m	Price decrease 1m	2.53 -0.1 (-3.8%)	Oct 16 06:47
Day	Rvol 10 increase day	rvol 10.05, 2.63 +0.28 (+11.91%)	Oct 16 06:46
1m	Price increase 1m	2.63 +0.03 (+1.15%)	Oct 16 06:46
1m	Price increase 1m	2.59 +0.08 (+3.19%)	Oct 16 06:45